Fund Overview

Fund Overview

Asclepius employs a multi asset class approach to the life sciences sector in order to provide absolute returns within a risk managed framework.

The Fund engages in active hedging to enhance returns, manage risk and lower volatility. Some hedging techniques employed may include short selling, pairs trading or option writing. All security positions are in deep and liquid markets. This rigorous, multi-discipline approach provides a comprehensive and highly scalable regime for investment success.

Although the General Partner does not anticipate that venture capital and private equity investments will account for more than 25% of the total net assets of the Fund, the General Partner has broad discretion to invest opportunistically in private equity and venture capital investments without limit.


| Accredited Investors

The information contained in this web site has been prepared solely for accredited investors. It is for informational purposes and is not an offer to sell or purchase or a solicitation of an offer to sell or purchase any interests or shares in any of the funds managed by Asclepius Investment Strategies, LLC Such offers are made only by way of a private offering memorandum delivered to qualified investors.

| Contact

641 Lexington Avenue, Suite 1337
New York, NY 10022
Phone: (212) 634-6440
Fax: (212) 634-6480